T1	Participants 428 507	patients with moderate asthma previously treated with an inhaled corticosteroid
T2	Participants 611 821	342 adolescent and adult patients with moderate asthma [forced expiratory volume in 1 second (FEV1) between 50% and 80% of predicted] treated previously by beclomethasone dipropionate or triamcinolone acetonide
T3	Participants 1997 2026	patients with moderate asthma
